Akero Therapeutics Inc (AKRO)
20.71
+0.41
(+2.02%)
USD |
NASDAQ |
May 15, 14:19
Akero Therapeutics Shares Outstanding: 69.15M for May 3, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
May 03, 2024 | 69.15M |
April 10, 2024 | 69.15M |
April 02, 2024 | 69.15M |
March 31, 2024 | 69.15M |
March 08, 2024 | 68.95M |
February 23, 2024 | 56.30M |
December 31, 2023 | 55.75M |
November 03, 2023 | 55.71M |
September 30, 2023 | 55.68M |
August 04, 2023 | 55.60M |
June 30, 2023 | 55.55M |
May 19, 2023 | 55.33M |
May 11, 2023 | 50.09M |
April 24, 2023 | 48.42M |
April 06, 2023 | 47.28M |
March 31, 2023 | 46.98M |
March 14, 2023 | 46.97M |
December 31, 2022 | 46.87M |
October 28, 2022 | 46.76M |
September 30, 2022 | 46.66M |
September 19, 2022 | 46.42M |
July 29, 2022 | 37.57M |
June 30, 2022 | 37.57M |
June 17, 2022 | 37.55M |
April 29, 2022 | 35.02M |
Date | Value |
---|---|
April 04, 2022 | 35.02M |
March 31, 2022 | 35.02M |
February 15, 2022 | 35.01M |
December 31, 2021 | 34.90M |
November 09, 2021 | 34.89M |
September 30, 2021 | 34.88M |
August 08, 2021 | 34.86M |
June 30, 2021 | 34.84M |
May 07, 2021 | 34.83M |
April 05, 2021 | 34.82M |
March 31, 2021 | 34.77M |
March 10, 2021 | 34.77M |
December 31, 2020 | 34.74M |
November 06, 2020 | 34.72M |
September 30, 2020 | 34.72M |
August 07, 2020 | 34.70M |
July 10, 2020 | 34.70M |
June 30, 2020 | 28.68M |
May 08, 2020 | 28.67M |
April 09, 2020 | 28.67M |
March 31, 2020 | 28.67M |
March 06, 2020 | 28.61M |
December 31, 2019 | 28.57M |
November 08, 2019 | 28.56M |
September 30, 2019 | 28.56M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
26.30M
Minimum
Jun 10 2019
69.15M
Maximum
Apr 10 2024
41.50M
Average
35.02M
Median
Shares Outstanding Benchmarks
89bio Inc | 98.38M |
Madrigal Pharmaceuticals Inc | 21.31M |
Viking Therapeutics Inc | 110.27M |
Ionis Pharmaceuticals Inc | 145.97M |
Galectin Therapeutics Inc | 61.90M |